Middle East and Africa Laboratory Developed Test Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Clinical Biochemistry, Critical Care, Haematology, Microbiology, Molecular Diagnostics, Immunology, and Other Test Types) and Application (Academic Institutes, Clinical Research Organizations, Hospitals Laboratory, Specialty Diagnostic Centers, and Others)
Market Introduction
A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed and used within a single laboratory. These tests can be utilized to estimate or distinguish an extensive assortment of analytes materials such as proteins, chemical compounds like glucose or cholesterol, or DNA, from a specimen received from human anatomy. The expansion of automated in vitro diagnostics (IVD) methods for labs and dispensaries to render precise, and error-free analysis is anticipated to fuel the increment.
Get more information on this report :
Market Overview and Dynamics
The Middle East and Africa laboratory developed test market is expected to reach US$ 869.59 million by 2028 from US$ 577.05 million in 2021; it is estimated to grow at a CAGR of 7.0% from 2021 to 2028. The continuous research on personalized medicine and rising automation of laboratory processes across the globe are factors propelling the laboratory developed testing market. However, the changing regulatory landscape is hampering the growth of the Middle East and Africa laboratory development test market.
LDTs play a vital role in developing personalized medicines that are likely to prove as promising means of tackling diseases through far eluded effective treatments or cures. As per the Personalized Medicine Coalition, personalized medicines accounted for only 5% of the new FDA-approved molecular entities in 2005; however, in 2016, this number rose to more than 25%. Additionally, 42% of all compounds and 73% of oncology compounds in the pipeline have the potential to serve as personalized medicines. Biopharmaceutical companies have nearly doubled their R&D investments in personalized drugs in the last five years across the globe. They are further expected to increase their investments by 33% in the next five years. Biopharmaceutical researchers also predict a 69% increase in the development of personalized medicines in the next five years. Personalized medicines are becoming the trademark of cancer treatment; it is a constantly emerging approach based on the customization of treatments per the individual genetic structure. In 2019, the FDA approved 12 personalized medications to investigate and address the root causes of disease: thus, combining precision medicine in clinical care. The rising demand for personalized medicine is, therefore, offering significant growth opportunities for the players operating in the MEA laboratory developed test market. Also, automation is emerging as an approach to minimize human involvement in laboratory processes boosting market growth.
Economic uncertainties and ongoing conflicts are worsening the condition in the Middle East. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflict and are unable to implement any public health measures. A sudden drop in domestic and external demand for goods and products, especially crude oil, and halted production due to labor shortage are significant impacts observed in the region. Additionally, tightened financial condition is decreasing the economic activities in Middle East. Thus, negatively impacting the growth of the laboratory developed test in the region.
Key Market Segments
The Middle East and Africa laboratory developed test market, by type, is segmented into clinical biochemistry, critical care, haematology, microbiology, molecular diagnostics, immunology, and other test types. The haematology segment was sub-segmented into coagulation and hemostasis, hemoglobin testing, blood count testing and others. The molecular diagnostics segment held the largest share of the market in 2021. However, the haematology segment is anticipated to register the highest CAGR during the forecast period.
The Middle East and Africa laboratory developed test market, by application, is segmented into academic institutes, clinical research organizations, hospitals laboratory, specialty diagnostic centers, and others. The hospitals laboratory segment held the largest share of the market in 2021. However, the specialty diagnostic centers segment is anticipated to register the highest CAGR during the forecast period.
Major Sources and Companies Listed
A few of the primary and secondary sources referred to while preparing the Middle East and Africa laboratory developed test market report are the South Africa Medical Devices Association (SAMED), SA Health Products Regulatory Authority (SAHPRA), and International Agency for Research on Cancer (IARC).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of Middle East and Africa laboratory developed test market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Middle East and Africa laboratory developed test market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Middle East and Africa laboratory developed test market.
MIDDLE EAST AND AFRICA LABORATORY DEVELOPED TEST MARKET SEGMENTATION
By Type
- Clinical Biochemistry
- Critical Care
- Haematology
- Coagulation and Hemostasis,
- Hemoglobin Testing
- Blood Count Testing
- Others
- Immunology
- Microbiology
- Molecular Diagnostics
- Other Test Types
By Application
- Academic Institutes
- Clinical Research organizations
- Hospitals laboratory
- Specialty Diagnostic Centers
- Others
By Country
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
Company Profiles
- Quest Diagnostics Incorporated
- F. HOFFMANN-LA ROCHE LTD.
- QIAGEN
- Illumina, Inc.
- Rosetta Genomics Ltd.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa Laboratory Developed Test Market – By Type
1.3.2 Middle East and Africa Laboratory Developed Test Market – By Application
1.3.3 Middle East and Africa Laboratory Developed Test Market – By Country
2. Laboratory Developed Test Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Laboratory Developed Test Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East and Africa – PEST Analysis
4.3 Experts Opinion
5. Laboratory Developed Test Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Cancer and Genetic Disorders
5.1.2 Large Number of Product Launches
5.2 Market Restraints
5.2.1 Changing Regulatory Landscape
5.3 Market Opportunities
5.3.1 Continuous Research on Personalized Medicine
5.4 Future Trends
5.4.1 Automation of Laboratory Processes
5.5 Impact Analysis
6. Laboratory Developed Test Market –Middle East and Africa Analysis
6.1 Middle East and Africa Laboratory Developed Test Market Revenue Forecast and Analysis
7. Laboratory Developed Test Market Analysis – By Type
7.1 Overview
7.2 Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)
7.3 Clinical Biochemistry
7.3.1 Overview
7.3.2 Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Haematology
7.4.1 Overview
7.4.2 Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Coagulation and Hemostasis
7.4.3.1 Overview
7.4.3.2 Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Hemoglobin Testing
7.4.4.1 Overview
7.4.4.2 Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Blood Count Testing
7.4.5.1 Overview
7.4.5.2 Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.6 Others
7.4.6.1 Overview
7.4.6.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Immunology
7.5.1 Overview
7.5.2 Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Critical Care
7.6.1 Overview
7.6.2 Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Microbiology
7.7.1 Overview
7.7.2 Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Molecular Diagnostics
7.8.1 Overview
7.8.2 Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Other Test Types
7.9.1 Overview
7.9.2 Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8. Laboratory Developed Test Market Analysis – By Application
8.1 Overview
8.2 Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)
8.3 Academic Institutes
8.3.1 Overview
8.3.2 Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Clinical Research organizations
8.4.1 Overview
8.4.2 Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Hospital laboratory
8.5.1 Overview
8.5.2 Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Specialty Diagnostic Centers
8.6.1 Overview
8.6.2 Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
9. Laboratory Developed Test Market – Middle East and Africa Analysis
9.1 Middle East and Africa: Laboratory Developed Test Market
9.1.1 Overview
9.1.2 Middle East & Africa: Laboratory Developed Test Market- Revenue and Forecast to 2028 (US$ Million)
9.1.3 Middle East and Africa Laboratory Developed Test Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.3.1 Middle East and Africa: Laboratory Developed Test Market, by Haematology Type, 2019–2028 (USD Million)
9.1.4 Middle East and Africa Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5 Middle East and Africa: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)
9.1.5.1 Saudi Arabia: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.1 Saudi Arabia: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.2 Saudi Arabia Laboratory Developed Test Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.1.2.1 Saudi Arabia: Laboratory Developed Test Market, by Haematology Type, 2019–2028 (USD Million)
9.1.5.1.3 Saudi Arabia Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5.2 UAE: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.1 UAE: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.2 UAE Laboratory Developed Test Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.2.2.1 UAE: Laboratory Developed Test Market, by Haematology Type, 2019–2028 (USD Million)
9.1.5.2.3 UAE Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5.3 South Africa: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.1 South Africa: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.2 South Africa Laboratory Developed Test Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.3.2.1 South Africa: Laboratory Developed Test Market, by Haematology Type, 2019–2028 (USD Million)
9.1.5.3.3 South Africa Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5.4 Rest of Middle East and Africa: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.4.1 Rest of Middle East and Africa: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.4.2 Rest of Middle East and Africa Laboratory Developed Test Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.4.2.1 Rest of Middle East and Africa: Laboratory Developed Test Market, by Haematology Type, 2019–2028 (USD Million)
9.1.5.4.3 Rest of Middle East and Africa Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Middle East and Africa Laboratory Developed Test Market
10.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11. Laboratory Developed Test Market–Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Quest Diagnostics Incorporated
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F.HOFFMANN-LA ROCHE LTD.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Illumina, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.6 Rosetta Genomics Ltd.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 The company’s financial information is not available in the public domain.
12.6.6 SWOT Analysis
12.6.7 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East and Africa Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Middle East and Africa Laboratory Developed Test Market, by Haematology Type – Revenue and Forecast to 2028 (USD Million)
Table 3. Middle East and Africa Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 4. Saudi Arabia Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 5. Saudi Arabia Laboratory Developed Test Market, by Haematology Type – Revenue and Forecast to 2028 (USD Million)
Table 6. Saudi Arabia Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 7. UAE Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. UAE Laboratory Developed Test Market, by Haematology Type – Revenue and Forecast to 2028 (USD Million)
Table 9. UAE Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 10. South Africa Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 11. South Africa Laboratory Developed Test Market, by Haematology Type – Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of Middle East and Africa Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of Middle East and Africa Laboratory Developed Test Market, by Haematology Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of Middle East and Africa Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 16. Recent Inorganic Growth Strategies in the Laboratory Developed Test Market
Table 17. Recent Organic Growth Strategies in the Laboratory Developed Test Market
Table 18. Glossary of Terms, Laboratory Developed Test Market
LIST OF FIGURES
Figure 1. Laboratory Developed Test Market Segmentation
Figure 2. Laboratory Developed Test Market Segmentation, By Country
Figure 3. Middle East and Africa Laboratory Developed Test Market Overview
Figure 4. Molecular Diagnostics Segment Held the Largest Share of the Type Segment in Laboratory Developed Test Market
Figure 5. Middle East and Africa Laboratory Developed Test Market – Leading Country Markets (US$ Million)
Figure 6. Middle East and Africa PEST Analysis
Figure 1. Laboratory Developed Test Market Impact Analysis of Drivers and Restraints
Figure 2. Middle East and Africa Laboratory Developed Test Market – Revenue Forecast and Analysis – 2020- 2028
Figure 3. Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)
Figure 4. Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 5. Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 6. Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 7. Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 8. Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 9. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)
Figure 16. Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Middle East and Africa: Laboratory Developed Test Market, by Key Country – Revenue (2021) (USD Million)
Figure 22. Middle East & Africa Laboratory Developed Test Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. Middle East and Africa: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)
Figure 24. Saudi Arabia: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
Figure 25. UAE: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
Figure 26. South Africa: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
Figure 27. Rest of Middle East and Africa: Laboratory Developed Test Market– Revenue and Forecast to 2028 (US$ Million)
Figure 28. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
- Quest Diagnostics Incorporated
- F. HOFFMANN-LA ROCHE LTD.
- QIAGEN
- Illumina, Inc.
- Rosetta Genomics Ltd.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa laboratory developed test market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa laboratory developed test market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.